| 内皮素与缺血性心脑血管疾病 |
| |
| 引用本文： | 崔敏,贡沁燕. 内皮素与缺血性心脑血管疾病[J]. 中国新药与临床杂志, 2005, 24(1): 64-68 |
| |
| 作者姓名： | 崔敏 贡沁燕 |
| |
| 作者单位： | 复旦大学上海医学院,药理学系,上海,200032 |
| |
| 摘 要： | 内皮素(ET)是一种血管收缩肽,与ET受体结合而发挥作用。ET不仅参与了机体正常生理功能的调节,而且参与了缺血性心脑血管疾病的病理过程,研制特异的ET受体拮抗剂用于缺血性心脑血管疾病的治疗已成为一个热点。
|
| 关 键 词： | 内皮缩血管肽类 心肌梗死 脑缺血 受体,内皮缩血管肽 |
| 文章编号： | 1007-7669(2005)01-0064-05 |
Endothelin and ischemic cardio-cerebrovascular disease |
| |
| CUI Min,GONG Qin-yan. Endothelin and ischemic cardio-cerebrovascular disease[J]. Chinese Journal of New Drugs and Clinical Remedies, 2005, 24(1): 64-68 |
| |
| Authors: | CUI Min GONG Qin-yan |
| |
| Abstract: | Endothelin(ET) is a recently discovered potent vasoconstrictor peptide exerting effects through combination with its receptor. ET participates not only in the regulation of physiological function, but also in the pathological course of ischemic heart disease and ischemic cerebrovascular disease. It is the hotspot for study and development of the specific ET receptor antagonists to treat ischemic cardio-cerebrovascular disease. |
| |
| Keywords: | endothelins myocardial infarction brain ischemia receptor endothelin |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
